Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients
Status:
Unknown status
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether the treatment of human menstrual
blood-derived mesenchymal stem cells which would be applied to diabetes patients is safe and
effective.